Insights

Expansion opportunity SubjectWell recently acquired Clariness GmbH to form one of the largest global full-service patient recruitment platforms, presenting a cross-border sales opportunity to expand services and integrate capabilities for a broader sponsor base.

Science-driven framework The launch of a Science-Driven Framework to transform protocol design, recruitment, engagement, and retention signals a consultative selling angle to offer advanced data-driven recruitment strategies and protocol optimization services.

Awarded credibility Multiple industry awards for marketing, design, and brand reinvention enhance SubjectWell’s credibility when approaching potential sponsors, CROs, and sites as a trusted partner in patient experience and recruitment.

Global reach As a global platform with acquisitions expanding scale, there is a clear opportunity to upsell international patient recruitment capabilities, diverse site networks, and cross-region study support to sponsors running global trials.

Technology stack Leveraging a mix of analytics, automation, and marketing tech (Workday Adaptive Planning, Google Ads, HubSpot, Pardot, Teradata) enables selling value around operational efficiency, predictive recruitment, and measurable campaign performance to stakeholders.

SubjectWell Tech Stack

SubjectWell uses 8 technology products and services including Workday Adaptive Planning, Google Ads, HubSpot Analytics, and more. Explore SubjectWell's tech stack below.

  • Workday Adaptive Planning
    Accounting And Finance
  • Google Ads
    Advertising
  • HubSpot Analytics
    Analytics
  • Teradata
    Business Intelligence
  • WordPress
    Content Management System
  • Continuous Delivery
    Continuous Integration
  • Pardot
    Marketing
  • WP Engine
    Platform As A Service

Media & News

SubjectWell's Email Address Formats

SubjectWell uses at least 1 format(s):
SubjectWell Email FormatsExamplePercentage
First.Last@subjectwell.comJohn.Doe@subjectwell.com
59%
First@subjectwell.comJohn@subjectwell.com
21%
Last@subjectwell.comDoe@subjectwell.com
16%
FLast@subjectwell.comJDoe@subjectwell.com
4%

Frequently Asked Questions

What is SubjectWell's phone number?

Minus sign iconPlus sign icon
You can contact SubjectWell's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SubjectWell's official website and social media links?

Minus sign iconPlus sign icon
SubjectWell's official website is subjectwell.com and has social profiles on LinkedInCrunchbase.

What is SubjectWell's NAICS code?

Minus sign iconPlus sign icon
SubjectWell's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SubjectWell have currently?

Minus sign iconPlus sign icon
As of July 2026, SubjectWell has approximately 160 employees across 3 continents, including AfricaNorth AmericaEurope. Key team members include Head Of Operations: F. D. O.Managing Director, Europe: T. K.Managing Director: C. M.. Explore SubjectWell's employee directory with LeadIQ.

What industry does SubjectWell belong to?

Minus sign iconPlus sign icon
SubjectWell operates in the Pharmaceutical Manufacturing industry.

What technology does SubjectWell use?

Minus sign iconPlus sign icon
SubjectWell's tech stack includes Workday Adaptive PlanningGoogle AdsHubSpot AnalyticsTeradataWordPressContinuous DeliveryPardotWP Engine.

What is SubjectWell's email format?

Minus sign iconPlus sign icon
SubjectWell's email format typically follows the pattern of First.Last@subjectwell.com. Find more SubjectWell email formats with LeadIQ.

How much funding has SubjectWell raised to date?

Minus sign iconPlus sign icon
As of July 2026, SubjectWell has raised $47M in funding. The last funding round occurred on Oct 18, 2022 for $35M.

When was SubjectWell founded?

Minus sign iconPlus sign icon
SubjectWell was founded in 2012.
SubjectWell logo

SubjectWell

Pharmaceutical ManufacturingTexas, United States51-200 Employees

SubjectWell is a global patient experience platform that supports clinical trial recruitment, engagement, and retention by optimizing the patient journey from protocol design through study completion. It serves sponsors, CROs, research sites, and site networks, appealing to organizations seeking predictable recruitment and improved trial experience through a combination of strategy, reach, scientific insight, services, and technology. The company positions itself within the pharmaceutical manufacturing landscape as a provider that delivers intelligence, predictability, and operational efficiency in clinical trial processes.
Based in Austin, Texas, SubjectWell has established itself as a player in the patient recruitment and trial optimization space, with recent strategic developments that include expanding its platform through acquisitions and launching a science-driven framework aimed at transforming protocol design and engagement. The organization has been active in industry events and has garnered recognition in design and marketing awards, reflecting its emphasis on patient-focused design and communication within the clinical trial ecosystem.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2012
Employees
51-200

Section iconFunding & Financials

  • $47M

    SubjectWell has raised a total of $47M of funding over 7 rounds. Their latest funding round was raised on Oct 18, 2022 in the amount of $35Mas a series_b.

  • $25M$50M

    SubjectWell's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $47M

    SubjectWell has raised a total of $47M of funding over 7 rounds. Their latest funding round was raised on Oct 18, 2022 in the amount of $35Mas a series_b.

  • $25M$50M

    SubjectWell's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.